Clinical Trial Update: T Cells and Pembrolizumab for Recurrent and Newly Diagnosed Glioblastoma [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial is evaluating pembrolizumab in combination with T cell therapy for recurrent and newly diagnosed glioblastoma. The study is currently…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Queensland Institute of Medical Research | Conditions: Glioblastoma Multiforme, Astrocytoma, Grade IV | Phase 1, Phase 2 | Status: RECRUITING